Matthew Bennett

Matthew Bennett

Amministratore Delegato presso Enterprise Consulting Solutions, Inc.

52 anni
Technology Services
Health Technology
Process Industries

Profilo

Matt Bennett, Managing Director, joined New Mountain in 2016.
He focuses on growth transactions across several sectors including medical devices, pharmaceuticals, health technology, materials, and sustainable infrastructure.
He serves on the Boards of HealthComp, Finvi, Real Chemistry, Covaris and Profile Products and works closely with additional NMC companies.
He previously served on the Boards of Datavant, Gelest, Alteon, Sparta Systems, and Cytel.
Mr. Bennett was previously CEO of CIOX Health (now Datavant).
Before that, he held multiple executive roles at Ikaria where he was Executive Vice President, Global Medical Operations, Chief Financial Officer, head of Corporate Development, and Chief Legal Officer.
Prior to joining Ikaria, he was Executive Vice President, Chief Administrative Officer and Chief Business Officer, at VIASYS Healthcare, Inc. (NYSE: VAS), where he was responsible for the company’s growth strategy and mergers and acquisitions.
Before VIASYS, he was a transaction leader on mergers and acquisitions, initial public offerings, and commercial transactions in health care at Morgan, Lewis & Bockius LLP, as well as a health care trial attorney at Stradley, Ronon, Stevens & Young.
He holds an AB in Political Science from Princeton University and a JD from Villanova University School of Law.

Posizioni attive di Matthew Bennett

SocietàPosizioneInizio
Direttore/Membro del Consiglio 01/01/2014
Amministratore Delegato -
Direttore/Membro del Consiglio 01/11/2020
Direttore/Membro del Consiglio 01/09/2019
Direttore/Membro del Consiglio 01/01/2021
Direttore/Membro del Consiglio 01/04/2017
Direttore/Membro del Consiglio 01/12/2021
Investitore di Private Equity 01/01/2016
Tutte le posizioni attive di Matthew Bennett

Precedenti posizioni note di Matthew Bennett

SocietàPosizioneFine
BELLEROPHON THERAPEUTICS, INC. Direttore/Membro del Consiglio 01/03/2021
░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Matthew Bennett

Formazione di Matthew Bennett

Villanova University School of Law Doctorate Degree
Princeton University Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Matthew Bennett

Relazioni

99

Relazioni di 1° grado

24

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa3
BELLEROPHON THERAPEUTICS, INC.

Health Technology

AVANTOR, INC.

Process Industries

BECTON, DICKINSON AND COMPANY

Health Technology

Aziende private19

Health Technology

Health Services

Health Technology

Commercial Services

Process Industries

Technology Services

Technology Services

Technology Services

Distribution Services

Commercial Services

Technology Services

Technology Services

Finance

Technology Services

Health Technology

Health Technology

Process Industries

Finance

Technology Services

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Matthew Bennett
-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA